Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
CNY 7.36
(-0.14%)
CNY 7.36
(-0.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 210.76 Million | 145.85 Million | 215.1 Million | 203.51 Million | 210.87 Million | 167.31 Million |
| Net Income | 94.73 Million | 88.31 Million | 104.69 Million | 89.61 Million | 92.33 Million | 84.9 Million |
| Depreciation & Amortization | 50.45 Million | 44.27 Million | 43.08 Million | 40.66 Million | 42.44 Million | 40.21 Million |
| Deferred income taxes | 2.15 Million | 2.13 Million | 2.69 Million | -1.7 Million | -1.27 Million | -533.54 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 55.47 Million | -1.33 Million | 52.82 Million | 50.84 Million | 38.15 Million | -684.51 Thousand |
| Other non-cash items | 53.38 Million | 14.6 Million | 14.49 Million | 22.39 Million | 37.94 Million | 42.87 Million |
| Investing Cash Flow | -71.6 Million | 1.76 Million | -207.06 Million | -75.83 Million | -21.62 Million | -69.47 Million |
| Investments in PPE | -35.77 Million | -41.36 Million | -107.06 Million | -75.93 Million | -21.69 Million | -73.72 Million |
| Acquisitions | 4.17 Million | 1.47 Million | 300.00 | 1.41 Million | 68.5 Thousand | 180.49 Thousand |
| Investment purchases | -100 Million | -80 Million | -100 Million | - | - | - |
| Sales/Maturities of investments | 60 Million | 123.13 Million | -300.00 | - | - | 4.06 Million |
| Other Investing Activities | -37.62 Million | -1.47 Million | 300.00 | -1.31 Million | -21.69 Million | 180.49 Thousand |
| Financing Cash Flow | 5.3 Million | -24.05 Million | -75.33 Million | 96.3 Million | -165.07 Million | -139.58 Million |
| Debt repayment | -40 Million | -400 Million | -415 Million | -360.47 Million | -590.38 Million | -660.38 Million |
| Dividends payments | -16.54 Million | -9.92 Million | -9.92 Million | -16.54 Million | -17.24 Million | -39.2 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.3 Million | 399.69 Million | 362.98 Million | 486.31 Million | 442.55 Million | 560 Million |
| Accounts receivables | 75.21 Million | -17.02 Million | -31.92 Million | -40.18 Million | -12.62 Million | 8.31 Million |
| Accounts payables | -7.08 Million | 18.53 Million | 64.2 Million | 77.18 Million | 16.83 Million | 20.77 Million |
| Inventory | -12.65 Million | -4.99 Million | 17.84 Million | 15.54 Million | 35.22 Million | -29.23 Million |
| Other working capital | -2.00 | 2.13 Million | 2.69 Million | -1.7 Million | -1.27 Million | 28.55 Million |
| Cash at beginning of period | 343.26 Million | 219.69 Million | 286.99 Million | 63.01 Million | 38.84 Million | 80.58 Million |
| Cash at end of period | 487.73 Million | 343.26 Million | 219.69 Million | 286.99 Million | 63.01 Million | 38.84 Million |
| Capital Expenditure | -35.77 Million | -41.36 Million | -107.06 Million | -75.93 Million | -21.69 Million | -73.72 Million |
| Effect of forex changes on cash | - | 0.33 | 0.73 | 0.77 | 0.77 | - |
| Net cash flow / Change in cash | 144.46 Million | 123.56 Million | -67.3 Million | 223.98 Million | 24.17 Million | -41.74 Million |
| Free Cash Flow | 174.99 Million | 104.49 Million | 108.03 Million | 127.58 Million | 189.17 Million | 93.59 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.52 Million | 12.31 Million | 21.01 Million | 94.73 Million | 36.26 Million | 11.04 Million |
| Depreciation & Amortization | - | 11.61 Million | 11.61 Million | 50.45 Million | 12.6 Million | -24.67 Million |
| Deferred income taxes | - | - | - | 2.15 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 55.47 Million | 62.56 Million | -56.76 Million |
| Other non-cash items | -479.67 Thousand | -1.53 Million | 23.73 Million | 53.38 Million | -64.88 Million | 116.46 Million |
| Investing Cash Flow | -2.36 Million | -390.84 Million | 39.5 Million | -71.6 Million | 325.33 Thousand | -6.5 Million |
| Investments in PPE | -2.38 Million | -579.37 Thousand | -12.84 Million | -35.77 Million | -3.79 Million | -6.5 Million |
| Acquisitions | 18.08 Thousand | 69.44 Thousand | 377.04 Thousand | 4.17 Million | 4.12 Million | 7766.76 |
| Investment purchases | -132.7 Thousand | -445 Million | - | -100 Million | 0.11 | - |
| Sales/Maturities of investments | 132.7 Thousand | 54.66 Million | 51.97 Million | 60 Million | -235.77 Thousand | - |
| Other Investing Activities | 18.08 Thousand | -444.93 Million | 52.35 Million | -37.62 Million | 235.77 Thousand | 7766.00 |
| Financing Cash Flow | -4.14 Million | -55.8 Million | -4.36 Million | 5.3 Million | -5.16 Million | -20.46 Million |
| Debt repayment | - | - | -140 Million | -40 Million | - | - |
| Dividends payments | -3.55 Million | -53.68 Million | -2.75 Million | -16.54 Million | -16.54 Million | -8.69 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -586.92 Thousand | -2.43 Million | -1.6 Million | -13.3 Million | 16.22 Million | -11.77 Million |
| Accounts receivables | - | - | - | 75.21 Million | 75.21 Million | -47.46 Million |
| Accounts payables | - | - | - | -7.08 Million | - | - |
| Inventory | - | - | - | -12.65 Million | -12.65 Million | -9.3 Million |
| Other working capital | - | - | - | -2.00 | - | - |
| Cash at beginning of period | 118.16 Million | 565.65 Million | 487.73 Million | 343.26 Million | 446.02 Million | 426.92 Million |
| Cash at end of period | 108.9 Million | 118.16 Million | 565.65 Million | 487.73 Million | 487.73 Million | 446.02 Million |
| Capital Expenditure | -2.38 Million | -579.37 Thousand | -12.84 Million | -35.77 Million | -3.79 Million | -6.5 Million |
| Effect of forex changes on cash | - | - | - | - | -1.00 | -0.25 |
| Net cash flow / Change in cash | -9.25 Million | -447.48 Million | 77.91 Million | 144.46 Million | 41.71 Million | 19.1 Million |
| Free Cash Flow | -338.1 Thousand | -1.4 Million | 31.9 Million | 174.99 Million | 42.74 Million | 39.55 Million |
BSS
MSUMI
0I6Q
4306
AEROFLEX
WCN